Literature DB >> 24220143

Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age.

Somayeh Hashemi1, Fahimeh Ramezani Tehrani2, Mahsa Noroozzadeh1, Fereidoun Azizi1.   

Abstract

OBJECTIVE: The normal cut-off values for hyperandrogenaemia differ between populations. Although there are various ways to determine the normal range of hormones in a population, use of a gold standard and the 95th percentile approach are not appropriate to diagnose hyperandrogenism. This study aimed to determine normative cut-off androgen levels for Iranian women of reproductive age using k-means cluster analysis. STUDY
DESIGN: The subjects were 1126 women, aged 18-45 years, initially selected at random from women of reproductive age from different geographic regions of Iran. Serum levels of hormones were measured, and complete data were available for 923 women following the implementation of exclusion criteria. The reference group comprised 423 eumenorrhoeic non-hirsute women selected from the total population. Normative cut-off levels were computed using k-means cluster analysis (k=3). Analyses were also conducted based on age and body mass index (BMI) groups for the 923 subjects.
RESULTS: Cluster cut-off values for the total study population were similar to the 95th percentile values, whereas the percentiles for the free androgen index, total testosterone, dehydroepiandrostenedione sulphate and androstenedione were 79.3%, 74.1%, 96.7% and 71%, respectively, in the reference group.
CONCLUSIONS: Determination of cut-off values for hyperandrogenism based on age and BMI categories provides the most objective way of determining normal upper limits of androgen levels among Iranian women of reproductive age.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dehydroepiandrosterone sulphate; Free testosterone; Hyperandrogenism; Normal cut-off value; Total testosterone

Mesh:

Substances:

Year:  2013        PMID: 24220143     DOI: 10.1016/j.ejogrb.2013.09.029

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population.

Authors:  Hasina Maredia; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Satupaitea Viali; Nicola L Hawley; Stephen T McGarvey
Journal:  Clin Biochem       Date:  2016-02-18       Impact factor: 3.281

2.  Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.

Authors:  Narges Zaeemzadeh; Shahideh Jahanian Sadatmahalleh; Saeideh Ziaei; Anoshirvan Kazemnejad; Azadeh Mottaghi; Neda Mohamadzadeh; Maryam Movahedinejad
Journal:  Int J Reprod Biomed       Date:  2020-04-30

3.  Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome.

Authors:  Narges Zaeemzadeh; Shahideh Jahanian Sadatmahalleh; Saeideh Ziaei; Anoshirvan Kazemnejad; Maryam Movahedinejad; Azadeh Mottaghi; Neda Mohamadzadeh
Journal:  J Ovarian Res       Date:  2021-01-09       Impact factor: 4.234

4.  The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.

Authors:  Mahbanoo Farhadi-Azar; Samira Behboudi-Gandevani; Maryam Rahmati; Fatemeh Mahboobifard; Ensi Khalili Pouya; Fahimeh Ramezani Tehrani; Fereidoun Azizi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

5.  Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis.

Authors:  Fahimeh Ramezani Tehrani
Journal:  Int J Endocrinol Metab       Date:  2015-07-01

6.  The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome.

Authors:  Samira Behboudi-Gandevani; Mehdi Hedayati; Mohammad Ali Mansournia; Maryam Nazemipour; Maryam Rahmati; Fahimeh Ramezani Tehrani
Journal:  Int J Endocrinol Metab       Date:  2021-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.